Ob/gyns and other women’s health providers can help save Title X for their patients and their voices need to be heard on Capitol Hill. That was the clear message from speakers at a recent media event in Washington, DC.
Obstetrics-Gynecology & Women's Health
The manufacturer of a device for permanent birth control that reportedly causes serious adverse events has decided to cease selling it at the end of the year. PLUS: Does smoking cessation really = weight gain? Also: Is prenatal depression more common today?
Risk of postop urinary retention may vary depending on when devices are removed.
Uropathogens may not be the only bacteria shared between the vagina and bladder.
Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.
Despite the prevalence of GSM, the condition continues to be under-recognized and undertreated due to a combination of patient and provider factors. Providers need to take the initiative in screening and patient education.
This article reviews recommendations for breastfeeding and current breastfeeding rates; positive maternal health outcomes associated with breastfeeding; and evidence-based practices that enable women to successfully achieve their breastfeeding goals.
An oral selective estrogen receptor modulator approved for treatment of mild to moderate dyspareunia in menopausal women reduced signs and symptoms of atrophy in the vulva, vestibule, urethral meatus and vagina region, according to results of a prospective open-label pilot study
In women with endometriosis, deep dyspareunia is associated with lower sexual quality of life (QoL), according to a study.
An ob/gyn shares her experience with implementing enhanced recovery after surgery (ERAS) and its effect on patient care at her institution